![]() |
| Signalling: Survival of the sweetest |
|
RSS FEED
|
Response rates to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in cancer treatment have been surprisingly and disappointingly low. Zhang Weihua and colleagues now shed some light on this issue by revealing a kinase-independent function of EGFR in maintaining cell survival.Using Read more... Source: Nature Reviews Cancer |
||||||||||||
|
|
|||||||||||||
| Signalling: Survival of the sweetest |
|
||
|
Site Map
|
Sitemap |

